# Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer

> **NCT03518242** · PHASE1 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 100 (actual)

## Conditions studied

- Breast Cancer Female
- Anatomic Stage IIB Breast Cancer AJCC v8
- Anatomic Stage III Breast Cancer AJCC v8
- Anatomic Stage IIIA Breast Cancer AJCC v8
- Anatomic Stage IIIB Breast Cancer AJCC v8
- Anatomic Stage IIIC Breast Cancer AJCC v8
- Invasive Breast Carcinoma
- Prognostic Stage IIB Breast Cancer AJCC v8
- Prognostic Stage III Breast Cancer AJCC v8
- Prognostic Stage IIIA Breast Cancer AJCC v8
- Prognostic Stage IIIB Breast Cancer AJCC v8
- Prognostic Stage IIIC Breast Cancer AJCC v8

## Interventions

- **DRUG:** Cyclophosphamide
- **DRUG:** Methotrexate
- **DRUG:** Capecitabine
- **PROCEDURE:** Biospecimen Collection

## Key facts

- **NCT ID:** NCT03518242
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-06
- **Primary completion:** 2022-05-04
- **Final completion:** 2022-05-04
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03518242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03518242, "Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03518242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*